Federal regulatory oversight of us clinics marketing adipose-derived autologous stem cell interventions: Insights from 3 new FDA draft guidance documents

Leigh G. Turner

doi:10.1016/j.mayocp.2015.02.003

Federal regulatory oversight of us clinics marketing adipose-derived autologous stem cell interventions: Insights from 3 new FDA draft guidance documents

Leigh G. Turner

Center for Bioethics

Research output: Contribution to journal › Short survey › peer-review

27 Scopus citations

Original language	English (US)
Pages (from-to)	567-571
Number of pages	5
Journal	Mayo Clinic Proceedings
Volume	90
Issue number	5
DOIs	https://doi.org/10.1016/j.mayocp.2015.02.003
State	Published - May 1 2015

Publisher link

10.1016/j.mayocp.2015.02.003

Find It

Find It at U of M Libraries

Cite this

@article{5107ca7628414666a4f2243a5c548a1d,

title = "Federal regulatory oversight of us clinics marketing adipose-derived autologous stem cell interventions: Insights from 3 new FDA draft guidance documents",

author = "Turner, {Leigh G.}",

year = "2015",

month = may,

day = "1",

doi = "10.1016/j.mayocp.2015.02.003",

language = "English (US)",

volume = "90",

pages = "567--571",

journal = "Mayo Clinic Proceedings",

issn = "0025-6196",

publisher = "Elsevier Science",

number = "5",

}

TY - JOUR

T1 - Federal regulatory oversight of us clinics marketing adipose-derived autologous stem cell interventions

T2 - Insights from 3 new FDA draft guidance documents

AU - Turner, Leigh G.

PY - 2015/5/1

Y1 - 2015/5/1

UR - http://www.scopus.com/inward/record.url?scp=84929484733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929484733&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2015.02.003

DO - 10.1016/j.mayocp.2015.02.003

M3 - Short survey

C2 - 25939934

AN - SCOPUS:84929484733

SN - 0025-6196

VL - 90

SP - 567

EP - 571

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

IS - 5

ER -

Federal regulatory oversight of us clinics marketing adipose-derived autologous stem cell interventions: Insights from 3 new FDA draft guidance documents

Publisher link

Find It

Other files and links

Cite this